Market Access Reuters Europe 2025: Using value propositions to improve acc... In a Reuters Pharma Europe 2025 fireside chat, NICE Advice Director Brad Grove spoke with Novartis's Matic Meglic about novel pharma payment models.
Market Access Reuters Europe 2025: Trade-offs in European launch sequencin... At Reuters, industry stakeholders discussed how, especially in light of the current tariff crisis, Europe must operate as a unit when pricing drugs.
Market Access Reuters Europe 2025: Collaboration key for innovation, BI he... At Reuters Pharma Europe, Francesco Di Marco of Boehringer Ingelheim focused on the importance of innovating together.
Digital Reuters Pharma Europe 2025: Access, AI dominate keynote talk... The opening sessions of Reuters Pharma Europe 2025 focused on global access challenges and the transformative potential of AI.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.